Enhanced Passive Safety Surveillance (EPSS) confirms an optimal safety profile of the use of MF59® -adjuvanted influenza vaccine in older adults: Results from three consecutive seasons.
Donatella PanattoMendel HaagPiero Luigi LaiSylvie TomczykDaniela AmiciziaMaria Maddalena LinoPublished in: Influenza and other respiratory viruses (2019)
Our analyses confirmed that the safety data observed were consistent with the known safety profile of Fluad™, which has been amply established over the last 20 years. No significant changes in the safety profile were observed.
Keyphrases